Innovation

Hybridoma AMS 9.1 (Murine IgD Igh-Ca)

University of Chicago
posted on 10/20/2009

This hybridoma produces monoclonal antibodies to the Fc portion of the murine IgD haplotype Igh-Ca. The antibodies are IgG2b, recognize mouse Igh-Ca, and have been demonstrated in flow cytometry, immunofluorescence and stimulation of B-cell proliferation.

Suggested Uses

Flow cytometry, immunofluorescence and stimulation of B-cell proliferation

Innovation Details
 

Detailed Description

IgD is the major antigen receptor isotype coexpressed with IgM on the surface of most peripheral B cells.(Note: No cross-reactivity with haplotypes Igh-Cb or Igh-Ce has been observed for this antibody.) Hybridoma Production: SJL mice were immunized with spleen cells from BALB/c mice and the resultant SJL splenocytes were fused with SP2/0 cells. Recognition of IgD haplotype Igh-Ca was confirmed by FACS analysis. References: Stall, A. and M. Loken (1984) "Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies" J Immunol 132(2):787 Goroff, D., A. Stall, J. Mond and F. Finkelman (1986) "In vitro and in vivo B lymphocyte-activating properties if monoclonal anti-d antibodies. I. Determinants of B-lymphocyte-activating properties" J Immunol 136:2382

File Number: 1122 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Heather Walsh at University of Chicago for more information.

Request more info via email request more info
People

Case Manager:

Heather Walsh Heather Walsh

Innovations (37)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,783 members 17,070 innovations 152 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...